AAAAAA
Results:
1-8
|
Results: 8
Authors:
Vanrenterghem, YFC
Citation: Yfc. Vanrenterghem, Tailoring immunosuppressive therapy for renal transplant recipients, PEDIAT TRAN, 5(6), 2001, pp. 467-472
Authors:
Kuypers, DR
Vanrenterghem, YFC
Citation: Dr. Kuypers et Yfc. Vanrenterghem, Prophylaxis of cytomegalovirus infection in renal transplantation - Reply, NEPH DIAL T, 16(11), 2001, pp. 2278-2279
Authors:
Maes, BD
van Pelt, JF
Peeters, JC
Nevens, F
Evenepoel, P
Kuypers, D
Messiaen, T
Fevery, J
Vanrenterghem, YFC
Citation: Bd. Maes et al., The effect of mycophenolate mofetil on hepatitis B viral load in stable renal transplant recipients with chronic hepatitis B, TRANSPLANT, 72(6), 2001, pp. 1165-1166
Authors:
Maes, BD
Kuypers, D
Messiaen, T
Evenepoel, P
Mathieu, C
Coosemans, W
Pirenne, J
Vanrenterghem, YFC
Citation: Bd. Maes et al., Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: Analysis of incidence and risk factors, TRANSPLANT, 72(10), 2001, pp. 1655-1661
Authors:
Vanrenterghem, YFC
Citation: Yfc. Vanrenterghem, Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine?, CURR OP NEP, 8(6), 1999, pp. 669-674
Authors:
Kuypers, DRJ
Vanrenterghem, YFC
Citation: Drj. Kuypers et Yfc. Vanrenterghem, Prophylaxis of cytomegalovirus infection in renal transplantation: new data for an old problem, NEPH DIAL T, 14(10), 1999, pp. 2304-2308
Authors:
Maes, BD
Vanwalleghem, J
Kuypers, D
Ghoos, Y
Rutgeerts, PJ
Vanrenterghem, YFC
Citation: Bd. Maes et al., Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine, TRANSPLANT, 68(10), 1999, pp. 1482-1485
Authors:
Vanwalleghem, JF
Vanrenterghem, YFC
Citation: Jf. Vanwalleghem et Yfc. Vanrenterghem, Hematologic considerations of organ transplantation, TRANSPLANTATION, 1999, pp. 685-695
Risultati:
1-8
|